Literature DB >> 9143570

High preoperative serum alanine transferase levels: effect on the risk of liver resection in Child grade A cirrhotic patients.

R Noun1, P Jagot, O Farges, A Sauvanet, J Belghiti.   

Abstract

Despite careful selection of cirrhotic patients with hepatocellular carcinoma (HCC), liver resection remains associated with a greater risk than in patients without underlying liver disease. In this study we assessed by multivariate analysis parameters associated with in-hospital mortality and morbidity in a selected group of 108 Child-Pugh A cirrhotic patients undergoing liver resection of HCC. The overall incidences of in-hospital deaths and postoperative complications were 8.3% and 48.1%, respectively. By univariate analysis, the preoperative serum alanine transferase (ALT) level (p = 0.001) and intraoperative transfusions (p = 0.01) were significantly associated with in-hospital death; however, only the serum ALT concentration was an independent risk factor. In-hospital mortality rates in patients whose serum ALT was below 2N (twofold the upper limit of the normal value), between 2N and 4N, and more than 4N were 3.9%, 13.0%, and 37.5%, respectively. An ALT level greater than 2N was predominantly observed in patients with a hepatitis C virus infection and significantly associated with histologic features of superimposed active hepatitis. Patients with an ALT level greater than 2N experienced an increased incidence of postoperative ascites (58% versus 32%, p = 0.01), kidney failure (16% versus 0%, p = 0.0003), and upper gastrointestinal bleeding (6.4% versus 0%, p = 0.02). These results indicate that the preoperative ALT level is a reliable predictor of in-hospital mortality and morbidity following liver resection in Child-Pugh A cirrhotic patients. Cirrhotic patients with ALT > 2N should undergo only a limited resection; if a larger resection is required, those patients should be considered for nonsurgical therapy or liver transplantation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9143570     DOI: 10.1007/pl00012259

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  8 in total

1.  Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence.

Authors:  Giorgio Ercolani; Gian Luca Grazi; Matteo Ravaioli; Massimo Del Gaudio; Andrea Gardini; Matteo Cescon; Giovanni Varotti; Francesco Cetta; Antonino Cavallari
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

2.  Low preoperative platelet counts predict a high mortality after partial hepatectomy in patients with hepatocellular carcinoma.

Authors:  Kazuhiro Kaneko; Yoshio Shirai; Toshifumi Wakai; Naoyuki Yokoyama; Kohei Akazawa; Katsuyoshi Hatakeyama
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

3.  Complete versus selective portal triad clamping for minor liver resections: a prospective randomized trial.

Authors:  Juan Figueras; Laura Llado; David Ruiz; Emilio Ramos; Juli Busquets; Antonio Rafecas; Jaume Torras; Juan Fabregat
Journal:  Ann Surg       Date:  2005-04       Impact factor: 12.969

4.  Modified technique of hepatic vascular exclusion: effect on blood loss during complex mesohepatectomy in hepatocellular carcinoma patients with cirrhosis.

Authors:  Xiao-ping Chen; Zhi-wei Zhang; Bi-xiang Zhang; Yi-fa Chen; Zhi-yong Huang; Wan-guang Zhang; Song-qing He; Fa-zu Qiu
Journal:  Langenbecks Arch Surg       Date:  2006-03-25       Impact factor: 3.445

Review 5.  HCC: current surgical treatment concepts.

Authors:  F Cauchy; D Fuks; J Belghiti
Journal:  Langenbecks Arch Surg       Date:  2012-06       Impact factor: 3.445

6.  Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths.

Authors:  S T Fan; C M Lo; C L Liu; C M Lam; W K Yuen; C Yeung; J Wong
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

7.  Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal.

Authors:  O Farges; B Malassagne; J F Flejou; S Balzan; A Sauvanet; J Belghiti
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

8.  Surgical treatment of hepatocellular carcinoma.

Authors:  Jacques Belghiti; Reza Kianmanesh
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.